Use of imiquimod for residual acral melanoma

BMJ Case Rep. 2014 Aug 21:2014:bcr2014203826. doi: 10.1136/bcr-2014-203826.

Abstract

Recent reports suggest that topical imiquimod cream is an effective treatment option for certain types of melanomas. No reports exist on the efficacy of using imiquimod cream to treat melanoma located on the plantar surface of the foot. We present two patients with a melanoma of the foot who had residual melanoma following surgical excision with acceptable margins. The patients were then treated with topical imiquimod for 8 weeks after which a repeat biopsy of the affected region showed no evidence of residual melanoma in situ. The use of topical imiquimod cream should be considered in the management of residual melanoma in situ of the plantar surface of the foot.

Publication types

  • Case Reports

MeSH terms

  • Administration, Cutaneous
  • Aged, 80 and over
  • Aminoquinolines / therapeutic use*
  • Antineoplastic Agents / therapeutic use*
  • Carcinoma in Situ / drug therapy*
  • Female
  • Follow-Up Studies
  • Foot Diseases / drug therapy*
  • Humans
  • Imiquimod
  • Male
  • Melanoma / drug therapy*
  • Melanoma, Cutaneous Malignant
  • Skin Cream
  • Skin Neoplasms / drug therapy*
  • Treatment Outcome

Substances

  • Aminoquinolines
  • Antineoplastic Agents
  • Imiquimod